Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
42.09
+1.02 (2.48%)
Apr 23, 2024, 1:56 PM EDT - Market open

Ionis Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
-366.29-269.72-28.6-444.26278.14273.740.35-60.4-88.28-38.98
Upgrade
Depreciation & Amortization
22.522.1119.5617.1614.0810.716.717.486.986.38
Upgrade
Share-Based Compensation
105.81100.26120.68230.12146.57131.3185.9872.1159.3131.38
Upgrade
Other Operating Activities
-69.53-127.02-80.84232.88-93.17187.1581.12-131.2943.117.51
Upgrade
Operating Cash Flow
-307.51-274.3730.835.89345.63602.91174.15-112.1121.136.29
Upgrade
Operating Cash Flow Growth
---14.19%-89.62%-42.67%246.20%--236.12%-90.10%
Upgrade
Capital Expenditures
-23.78238.36-11.96-35.12-30.91-13.61-34.76-7.11-7.69-7.52
Upgrade
Acquisitions
0000002.514.4725.5322.95
Upgrade
Change in Investments
-186.14-496.62212.81315.53-4.99-911.91-322.9463.66-73.83-94.69
Upgrade
Other Investing Activities
-4.21-4.38-5.95-5.93-5.38-4.04-3.09-4.42-4.06-3.59
Upgrade
Investing Cash Flow
-214.13-262.64194.91274.48-41.27-929.56-358.2956.6-60.05-82.85
Upgrade
Share Issuance / Repurchase
49.446.37101.32-38.51141.38475.8794.6713.4224.8923.07
Upgrade
Debt Issued / Paid
562.29-50.72297.96086.570-23.98-3.07-0.5635.05
Upgrade
Other Financing Activities
32.35-10.95-153.35-558.1-127.93-158.41.040.41.46
Upgrade
Financing Cash Flow
644.08-55.3245.93-596.61100.02475.87229.0911.3924.7359.59
Upgrade
Exchange Rate Effect
0.35-0.42-0.110.620.09-0.020000
Upgrade
Net Cash Flow
122.79-592.72471.53-285.62404.47149.1944.95-44.11-14.2-16.98
Upgrade
Free Cash Flow
-331.3-36.0118.840.77314.72589.3139.39-119.2113.43-1.23
Upgrade
Free Cash Flow Growth
--2340.93%-99.75%-46.59%322.78%----
Upgrade
Free Cash Flow Margin
-42.06%-6.13%2.33%0.11%28.04%98.27%27.11%-31.98%4.73%-0.58%
Upgrade
Free Cash Flow Per Share
-2.31-0.250.130.012.254.451.12-0.990.11-0.01
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).